The protective effect of dimethyl urea, a hydroxyl radical scavenger, against low-dose streptozotocin-induced diabetes has been evaluated. Dimethyl urea was given to C57BL/KsJ mice before five daily injections of streptozotocin. The saline pre-treated control animals became gradually hyperglycaemic, whereas the dimethyl urea treated group remained normoglycaemic during the 11 week follow-up period. Two weeks after the first streptozotocin injection, six out of ten dimethyl urea-treated and 12 out of 15 saline-treated mice had insulitis. Four or 11 weeks after the streptozotocin treatment, insulitis was rare in both groups. Multiple injections of dimethyl urea only did not affect the serum glucose concentrations or the islet morphology. It is suggested that dimethyl urea protected against hyperglycaemia by reducing the/3-cell cytotoxic effects of the low doses of streptozotocin. An increased number of cells would thus be preserved and the animals less prone to develop diabetes, despite the presence of an inflammatory process in the pancreatic gland.
One animal model for human insulin-dependent diabetes that has attracted a great deal of interest during recent years is the multiple streptozotocin (STZ)-induced diabetes in the mouse originally described by Like and Rossini [1] . This model is characterized by both a gradual development of hyperglycaemia and a round cell infiltration of the pancreatic islets leading to marked insulitis.
Although an autoimmune component seems to be involved in the aetiology of multi-STZ diabetes, the direct cytotoxic effects of STZ must be kept in mind. In line with this, compounds known to reduce STZ/3 cellcytotoxicity would be worthwhile testing. Indeed, it has been found that 3-0-methyl-glucose and nicotinamide attenuate the diabetic syndrome induced by multiple STZ injections [2] . Recent investigations have suggested that free oxygen radicals may participate in STZ/3 cell injury [3] [4] [5] [6] [7] [8] . However, Gold et al. did not observe any influence on the diabetic state induced by multiple STZ doses by pre-treatment with the superoxide anion scavenging enzyme superoxide dismutase [9] .
In the present study the effect of pre-treatment with the hydroxyl radical scavenger dimethyl urea (DMU) before multiple low doses of STZ on the development of hyperglycaemia and pancreatic insulitis have been examined. DMU was recently found partly to protect against diabetes induced by a single diabetogenic dose of STZ [5] .
Materials and methods

Animals
Inbred male C57BL/KsJ mice, originally obtained from the Jackson Laboratory, Bar Harbor, Maine, USA, aged 12-16 weeks, were used. The animals were allowed free access to tap water and laboratory chow (Ewos, Anticimex, Type R 3, S6dert~ilje, Sweden) throughout the experiments.
Treatment
The mice were pretreated 'intraperitoneally with either DMU-solution (20 ~ 4 g/kg body weight; Sigma Chemicals, St. Louis, Missouri, USA) or an equal volume of saline (9 g/l, 500 ~tl) 30 min before the daily injections of STZ. STZ (kindly provided by Dr. W. E. Dulin; lot 60, 273-5 U-9889, Upjohn, Kalamazoo, Michigan, USA) was dissolved immediately before use in cold citrate buffer (10mmol/1, pH 4.5) and given intraperitoneally (40 mg/kg body weight, 200 gl) for 5 consecutive days. Blood samples from the non-fasted animals were collected once or every second week without anaesthesia by retroorbital sinus puncture. Serum glucose was assayed using an automated analyser (Glucose Analyzer 2, Beckman Instruments, Fullerton, California, USA). In a series of control experiments, the animals were given multiple DMU or saline injections only, 30 min before intraperitoneal injections of citrate buffer. Serum glucose values (mean + SEM when exceeding 10% of the mean) for C57BL/KsJ mice given five daily injections of streptozotocin (40 mg/kg body weight, intraperitoneally) pre-treated with either dimethyl urea ( 9 9 : 4 g/kg body weight, intraperitoneally) or saline (0----0 : 9 g/l; 500 .ul, intraperitoneally) * p < 0.001 when using unpaired t-test Table 1 
Morphology
The animals were killed by cervical distension after 14, 21, 28 and 77 days and the pancreases were removed quickly, fixed in Bouin's solution and embedded in paraffin. Sections (7 ~m thickness) were cut and stained with hematoxylin eosin. The islet morphology was examined by a light microscope (Leitz, Wetzlar, FRG), with the examiner unaware of the origin of the pancreatic sections. The islet morphology was ranked according to four arbitrary classes by light microscopy [5] . (A) essentially normal islet morphology; (B) slight mononuclear cell infiltration in the peri-insular tissue; (C) cell infiltration into a majority of the islets, i.e. insulitis; (D) diabetic appearance with only a few remaining small and partially disintigrated islets with pycnotic nuclei.
Statistical analysis
Groups of data were compared using Student's t-test
Results
There was a gradual increase in the serum glucose concentrations of the multi-STZ-treated mice pretreated with saline during the ll-week follow-up period (Fig. 1) . In contrast, the animals given DMU and STZ treatment remained normoglycaemic throughout the whole observation period. Since the serum glucose concentrations of the DMU-treated animals did not increase, some of these mice were sacrificed after 4 instead of 2 weeks to ascertain a possible delay in the development of hyperglycaemia.
In control experiments, animals given five multiple doses of DMU or saline before citrate injections remained normoglycaemic. The serum glucose concentrations of the DMU-treated animals were 6.9+0.2 (n = 13), 7.8 _+ 0.3 (n = 13) and 8.0 + 0.3 (n = 7) mmol/1 and the saline-treated animals 8. The results of the morphological examinations of the STZ-treated animals are summarized in Table 1 . The highest frequency of insulitis in both groups was observed 14 days after starting the STZ regimen. Six out of ten DMU-treated and 12 out of 15 saline-treated animals were classified as having insulitis. A similar incidence of insulitis was found in the pancreatic glands after 3 weeks. Animals sacrificed after 4 and 11 weeks showed virtually no signs of insulitis. A majority of the saline pre-treated mice at that time displayed diabeticlike pancreatic morphology with only a few non-infiltrated islets remaining in the glands (Class D). Often pancreatic sections from both categories of animals obtained during weeks 2 and 3 after STZ injections exhibited lymph nodes within the pancreatic parenchyma and in the periglandular fat tissue.
Discussion
The present finding that pre-treatment with a drug that reduced the B-cell toxic action of STZ [5, 8] , protected against multi-STZ induced hyperglycaemia, suggests that direct STZ cytotoxicity is of importance for the development of diabetes in the multi-STZ model. This is in agreement with the findings of Bonnevie-Nielsen et al. that a major loss of fl cells and a concomitant decrease of insulin release capacity precede hyperglycaemia, as welt as the peak incidence of insulitis [10] .
The fact that a large proportion of the DMU-treated animals sacrificed on days 14 and 21 exhibited insulitis, but remained normoglycaemic, may suggest that the inflammatory reaction is not directed against the fl cells. Thus, the role of insulitis in the development of hyperglycaemia in this animal model may be insignificant as suggested previously [11, 12] . It could be also that a direct cytotoxic action of STZ is a prerequisite for induction of insulitis [2] . Animals given a drug (DMU) that re-duces repeated minor STZ cytotoxic effects, would be less susceptible to suffer a diabetogenic immune reaction.
In a previous investigation, we found that multi-STZ hyperglycaemic mice, which had been cured with syngeneic islets implanted intrasplenically, reverted to hyperglycaemia when given three small doses of STZ. Similarly, cured animals rendered diabetic by a single STZ injection remained normoglycaemic [13] . These results suggested that the multi-STZ treatment had induced immune reactions directed against the fl cells when exposed to STZ. Thus, it may be that when these animals were re-exposed to a low STZ dose, an immune response was elicted of such magnitude that hyperglycaemia developed. It has been proposed that human diabetes may result from cumulative r-cell damage induced by sequential environmental insults by toxic chemicals and infectious virus [14] . A few reports have also presented suggestive data that chemical agents may possess a diabetogenic action in man [15, 16] . It remains to be shown that these noxious agents are of importance in human diabetes. If so, prophylactic treatment of individuals who might be expected to develop insulin-dependent diabetes mellitus using free radical scavengers could be considered.
